Novotech Appoints Dr. Yooni Kim as a New Executive Position of Managing Director for APAC to Strengthen Global Expansion
Novotech, the leading global biotech Contract Research Organization (CRO), is pleased to announce the appointment of Dr. Yooni Kim as a new Executive position of Managing Director for the Asia-Pacific (APAC) region, effective September 1, 2024.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240911865593/en/
Dr. Yooni Kim, Managing Director APAC, Novotech (Photo: Business Wire)
This strategic appointment is part of Novotech's ongoing efforts to expand its global footprint and enhance its operational capabilities, positioning itself as a world-leader across all phases of clinical trials. As Novotech has scaled into a global entity, we have reaffirmed our commitment to maintaining a balance between global consistency and local responsiveness. The establishment of the Managing Director APAC role is a significant step achieving this, while aligning Novotech’s operations across key regions, including the United States, Europe, Mainland China, and APAC.
Dr. Yooni Kim brings extensive expertise and leadership experience to her new role, with over 25 years’ experience in the clinical research sector of academia, CROs and pharmaceutical companies. Her leadership was proven by a quantum leap in business growth in the APAC region within the CRO industry. Dr. Kim joined Novotech in 2016 as Executive Director, where she played a pivotal role in the growth of the company’s business in Asia. Following the PPC group merger in 2019, she served as Vice President of Global Clinical Services, leading the Novotech’s global clinical services departments and harmonizing Novotech’s approach to clinical trials with stakeholders globally. She holds a B. Pharm from Ewha Womans University and a Ph.D in Preventive Medicine from Seoul National University.
“We are delighted to have Dr. Yooni Kim lead our APAC region,” said Dr. John Moller, Novotech CEO. “Her deep understanding of the clinical research landscape in Asia, how this integrates into the global clinical research environment, and her leadership skills, will be invaluable as we continue to expand and strengthen our presence in this critical region.”
In her new role as Managing Director for APAC, Dr. Kim will lead Novotech’s APAC from providing strategic direction to diverse teams and ensuring operational excellence in the region. Dr. Kim said, “I am delighted to take this role. I bring a strategic approach to make growing Novotech’s capabilities stronger in the region. I will be organized to prioritise the needs of customers and ensure to deliver exceptional value and service for our customers. I will continuously focus on keeping strong bonds with key opinion leaders (KOLs), regulatory bodies and reinforcing clinical trial site partnerships in the region. I believe this will help leverage the extensive capabilities of the region to benefit our client’s clinical trials programs.”
“APAC is a critical region for Novotech’s business, hence this appointment gives the region a highly experienced leader with a customer-centric approach to oversee all aspects of operations and management areas, with the aim to provide our clients with reliable, actionable outcomes in their clinical trials program,” Dr. Moller added.
Dr. Kim will also join Novotech’s Executive Committee, where she will offer valuable contributions to the company's strategic direction and global initiatives.
Novotech remains committed to refining and optimizing its organizational structure to support its continued commitment to being biotech’s partner at every phase.
About NovotechNovotech-CRO.com
Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase.
Recognized for its industry-leading contributions, Novotech has received numerous prestigious awards, including the CRO Leadership Award 2023, the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence 2023, the Asia-Pacific Contract Research Organization Company of the Year Award since 2006.
The Company offers a comprehensive suite of services including laboratories, Phase I facilities, drug development consulting, regulatory expertise, and has experience with over 5,000 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. With a presence in 34 office locations and a dedicated team of 3,000+ professionals worldwide, Novotech is a trusted end-to-end strategic partner of choice.
For more information or to speak to an expert team member visit www.Novotech-CRO.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240911865593/en/
Contacts
Media
Toyna Chin
mediacontact@novotech-cro.com
USA: +1 415 364 8135
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mouser Electronics Explores Sustainable Smart Grid Innovation in Latest Content Series11.9.2024 17:41:00 CEST | Press release
Mouser Electronics, Inc., the authorized global distributor with the newest electronic components and industrial automation products, today released the latest installment of its Empowering Innovation Together (EIT) technology series, which explores the benefits of incorporating renewable energy into smart grid technology, emphasizing the role of AI and 5G in achieving sustainable grid management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240911011855/en/ In the latest installment of its Empowering Innovation Together (EIT) technology series, Mouser explores the benefits of incorporating renewable energy into smart grid technology, emphasizing the role of AI and 5G in achieving sustainable grid management. (Photo: Business Wire) Adopting a smart grid system enhances the precision of power usage monitoring and energy distribution and enables two-way communication between the system and users. This decentralized approach
Delinea Named a Leader in 2024 Gartner ® Magic Quadrant™ for Privileged Access Management11.9.2024 17:30:00 CEST | Press release
Delinea, a pioneering provider of solutions for securing identities through centralized authorization, today announced its recognition as a Leader in the 2024 Gartner Magic Quadrant for Privileged Access Management (PAM). This marks the 6th consecutive time that Delinea has been acknowledged in the Leaders Quadrant; Delinea stated that, in their opinion, this highlights the company's ongoing commitment to delivering market-trusted security solutions. “We are honored to be recognized once again as a Leader by Gartner,” said Art Gilliland, CEO of Delinea. “Identity security serves as the first line of defense, as every identity, both human and non-human, and the data with which they interact are targets in today’s modern enterprises. I believe this acknowledgement reaffirms our commitment to safeguarding our clients while delivering solutions that not only enhance security but also remove complexity, elevating the user experience.” As Gartner states, “growth continues to be driven by the
CyberArk Named a Leader in the 2024 Gartner® Magic Quadrant™ for Privileged Access Management11.9.2024 17:04:00 CEST | Press release
CyberArk (NASDAQ: CYBR), the identity security company, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Privileged Access Management.1 CyberArk is positioned as a Leader for the sixth consecutive time and is positioned furthest in Completeness of Vision, which evaluates vendors on offering (product) strategy, innovation and market understanding among other evaluation criteria. With 93% of organizations suffering two or more identity-related breaches in the last 12 months, managing and securing identities has become a critical requirement. The CyberArk Identity Security Platform enables organizations to secure the entire spectrum of identities, including workforce, IT, developer and machine, supporting modern access use cases such as the need to enforce Zero Standing Privileges in public cloud environments. A core component of the platform is CyberArk’s privileged access management (PAM) capabilities, which allow customers to apply flexible privilege
Spencer Health Solutions Achieves ISO 27001 Certification11.9.2024 15:55:00 CEST | Press release
Spencer Health Solutions (SHS), a healthcare technology leader in smart medication management, announced that it has achieved ISO 27001:2022 certification. This prestigious accreditation underscores the company's unwavering commitment to safeguarding patient data and ensuring the highest standards of information security. ISO 27001 is a globally recognized information security management system (ISMS) standard that ensures organizations implement robust measures to protect their assets from threats. By achieving this certification, Spencer Health Solutions has demonstrated its dedication to: Confidentiality: Protecting patient data from unauthorized disclosure. Integrity: Ensuring the accuracy and completeness of medication dispensing records. Availability: Guaranteeing timely access to medication dispensing information when needed. “We are proud to announce that Spencer Health Solutions has achieved ISO 27001 certification,” said Tom Rhoads, CEO of Spencer Health Solutions. “This acco
Experian Named to Fortune’s 2024 “100 Best Workplaces in Technology” List11.9.2024 15:00:00 CEST | Press release
Experian North America has been named to the prestigious Fortune Best Workplaces in Technology™ 2024 rankings. This honor spotlights Experian’s high-performing workplace culture that promotes innovation, inclusivity and equity, and team member well-being, growth and advancement. In determining this year’s 100 Best list, Fortune partnered with the people analytics firm Great Place to Work® to survey more than 870,000 employees and gathered data from companies representing more than 6.1 million employees. The survey enabled employees to share confidential feedback about their organization’s culture by responding to 60 statements that – when put together – describe a great employee experience, defined by high levels of trust, respect, credibility and more. “This recognition reflects our team members’ hard work in harnessing advanced technology to solve complex problems for our clients and our continuous improvement in building an even stronger, more connected workplace,” said Jennifer Sch
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom